ΔM4:具有抗瘤潜力的膜活性,可对抗人类皮肤癌细胞
Estefanía Fandiño-Devia1, Gloria A Santa-González2, Maria C Klaiss-Luna1
1Chemistry Institute, Faculty of Exact and Natural Sciences, University of Antioquia, A.A. 1226, Medellin 050010, Colombia.
Membranes
|July 28, 2023
概括
酸 ΔM4 选择性地向癌细胞,对黑色素瘤和表皮癌细胞系的活性是非瘤细胞的五倍. 它破坏了癌细胞膜,并诱导了胺转位,表明其作为癌症向剂的潜力.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 类是癌症治疗的有希望的药物,因为它们对癌细胞具有选择性亲和力.
- 了解与细胞膜的相互作用对于开发向癌症治疗至关重要.
研究的目的:
- 评估M4对黑色素瘤 (A375) 和表皮癌 (A431) 细胞系的生物活性和作用机制.
- 为了比较 ΔM4 对癌细胞和非瘤 HaCaT 细胞的影响.
- 调查 ΔM4.4 的破坏膜和诱导细胞死亡的特性.
主要方法:
- 用MTT试验评估了细胞毒性.
- 通过乳酸脱酶释放和Sytox吸收试验来评估膜完整性.
- 使用红外光谱学研究了-膜相互作用.
- 氨酸氨酸转位通过使用附件V-PE合剂的流细胞计确定.
主要成果:
- 与HaCaT细胞相比,ΔM4对A375和A431癌细胞的细胞毒性高出五倍.
- ΔM4显示出显著的膜活性和癌细胞的透性增加,特别是12.5μM的A431.
- 红外光谱检测显示, ΔM4 在 >5%的分子度下使瘤脂质系统流化.
- 流细胞测量表明,12.5μM的ΔM4诱导了A375和A431细胞中的酸胺转位.
结论:
- ΔM4 对癌细胞具有选择性细胞毒性.
- ΔM4通过膜破坏和诱导与亡相关的脂素转位来发挥其抗癌作用.
- 这些发现支持了 ΔM4 作为黑色素瘤和表皮癌的向治疗剂的潜力.
更多相关视频
08:26MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
14.6K
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
14.4K
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
